$CRSP News Article - CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001(TM) for the Treatment of Sickle Cell Disease
https://marketwirenews.com/news-releases/cris...46922.html